The Indian Pharmacological Society (IPS), Bengaluru Chapter and the
Karnataka College of Pharmacy (KCP), Bengaluru are jointly organising
the three-day 46th Annual Conference of Indian Pharmacological Society
referred to as the IPSCON – Bengaluru 2013 between December 16 and 18,
2013. The venue is the NIMHANS Convention Centre. The event is known as
the International Conference On Translational Pharmacology with the
theme as ‘Translating Research to Therapy’.
The conference comes to Bengaluru after 25 years when it was held in 1987 at the St John’s Medical College.
Over
2500 delegates from India and overseas are expected to attend the
event. Dr Jagdish Prasad, director general of health services,
Government of India, Dr Sharanprakash Patil, Karnataka Minister for
Medical Education and SR Patil, Karnataka Minister for Planning &
Statistics, IT & BT and Science & Technology will be
inaugurating the conference.
Pharmacologists play a key role in
all the aspects of drug like drug design, drug development, drug
research, drug safety, etc. With the theme of the conference as
'Translating Research to Therapy', there is already considerable ongoing
drug discovery research in India. However, rarely research outcome is
commercialized for the benefit of the population. Hence, the conference
aims at guiding the pharmacologists to carry on research that benefits
mankind in treatment, stated Dr Raju Koneri, professor of Pharmacology-
dean, Karnataka College of Pharmacy, president, Indian Pharmacological
Society, Bengaluru Chapter and organising secretary of IPSCON2013.
The
conference will be a platform for senior faculty from India and
overseas to discuss the recent advances in drug development and advances
in pharmacotherapy.
Specific to drug development, there would be
symposia on innovative therapies and challenges to pharmacology,
preclinical evaluations in developing clinical acceptance, drug
discovery current aspects and advances in traditional, natural system of
medicine.
There will be extensive deliberations on the current
issues in clinical research and the aspiration and vision for
pharmacovigilance in India
